The IVD Market in Vietnam

  • ID: 3398428
  • Report
  • Region: Vietnam
  • 43 Pages
  • Kalorama Information
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories, S.A.
  • bioMerieux
  • Roche
  • Siemens Healthcare
  • Sysmex
  • MORE
The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry.  Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia.  As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam. 

The report takes an in-depth look at the market, providing data on the size and growth of the total Vietnamese market.The report also provides segment market size and forecast for the following Vietnamese market segments:

- Clinical Chemistry 
- Microbiology-ID/AST 
- Microbiology-Molecular 
- POC Glucose 
- Other Point of Care 
- Immunoassays Infectious Disease 
- Other Immunoassays 
- Urinalysis 
- Molecular Diagnostics 
- Coagulation 
- Histology 
- Hematology 
- Blood Testing and Typing 
- Flow Cytometry 

A large population, growing healthcare infrastructure, growing economy and the presence of international IVD companies make the nation of interest to competitors and investors in in vitro diagnostics.  Vietnam spends a bit higher as a percentage of its GDP than its neighbors and the government is making significant investments in national healthcare infrastructure.   As part of its coverage, the report contains: 

- Vietnam Hospital Statistics
- Analyst Conclusions
- Urban Population of Vietnam Versus Other Countries 
- Vietnam Birth Rate
- Economy of Vietnam and Region
- Out of Pocket Spending
- Regional IVD Markets
- Disease Statistics
- Structure of Healthcare System
- Company Office Locations and Major Activities

This report places Vietnam and its IVD market in context with the developing world in terms of diseases, economic and healthcare system development, and other key metrics related to health expenditures and diagnostics.   Recent activity of international IVD Companies in Vietnam is presented.  The report provides information regarding the IVD industry and company investment and activity in Vietnam IVD in Vietnam presents the main issues and trends affecting this market, influencing its move into the future. The report presents eight major conclusions regarding the Vietnamese market as well.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories, S.A.
  • bioMerieux
  • Roche
  • Siemens Healthcare
  • Sysmex
  • MORE
ONE: EXECUTIVE SUMMARY
Size of the Healthcare Market and Forecast
Conclusions
TWO: INTRODUCTION
Healthcare Spending
Organization of Healthcare
Insurance
Clinical Laboratories
THREE: TRENDS
Health Status of Vietnamese
Diabetes
Tuberculosis
Stroke and Coronary Heart Disease
HIV/AIDS
Cancer
Influenza
Vietnam Medical Tourism
U.S. CDC Improves Design and Quality of Medical Laboratories in Vietnam
Bribery Scandal
International IVD Companies in Vietnam
bioMerieux
Roche
Abbott Laboratories, S.A.
Siemens Healthcare
Sysmex
FOUR: IVD MARKET IN VIETNAM
Size of the Market and Growth
IVD Market by Region
Clinical Chemistry
Point of Care Diabetes
Point of Care, Other
Immunoassays, Infectious Disease and Other
Urinalysis
Molecular Diagnostics
Coagulation
Histology
Hematology
Blood Testing and Typing
Flow Cytometry
Total Market by Segment
LIST OF EXHIBITS
ONE: EXECUTIVE SUMMARY
Figure 1-1: Population of Vietnam
Figure 1-2: Population and GDP Growth Compared, 2000-2015
Figure 1-3: Vietnam IVD Market, 2014 and 2019 ($millions)
TWO: INTRODUCTION
Figure 2-1: Urban Population of Vietnam Versus Other Countries, Percent(Vietnam,Thailand, Malaysia, China)
Figure 2-2: Births Rates by Select Country, 2014 Estimates (Singapore, Germany, Japan,Taiwan, Greece, Italy, Switzerland, Canada, Spain, Thailand, Australia, United Kingdom,Sweden, China, France, Russia, United states, Brazil, Vietnam, Indonesia, Argentina, Turkey,Mexico, venezuela, South Africa, India, Malaysia, Pakistan, Philippines, Iraq, Afghanistan,Mali, Niger)
Figure 2-3: Asia Pacific Region: Aging Populations by Year and Select Country--2007, 2014,2021 (India, China, Indonesia, Pakistan, Philippines, Vietnam, Iran, Afghanistan, Japan, Iraq,Thailand, S. Korea, Malaysia, Australia, Taiwan, N. Korea, Singapore, ROAP)
Figure 2-4: Vietnam Population Compared (Singapore, Indonesia, Thailand, Laos, Cambodia,Vietnam, Australia)
Figure 2-5: Vietnam Economy Compared (Singapore, Indonesia, Thailand, Laos, Cambodia,Vietnam, Australia)
Table 2-1: Vietnam Major Cities Population (Ho Chi Minh City, Hanoi, Haiphong, Ðà N?ng,C?n Tho, Biên Hòa City, Nha Trang, Buôn Ma Thu?t, Hu?)
Figure 2-6: Healthcare Spending as a Percentage of GDP Compared, Vietnam vs. Other Nations (United States, Germany, Brazil, Vietnam, China, Thailand, India, Philippines,Singapore, Malaysia)
Figure 2-7: Hospitals in Vietnam, 2007-2013
Figure 2-8: Physicians, Assistants, Nurses in Vietnam, 2009-2013
Table 2-2: Healthcare System Capacities – Vietnam and Comparison Countries(Australia,Brazil, China, France, Germany, India, Indonesia, South Korea, Mexico, Nigeria, Poland,Russia, South Africa, Thailand, Turkey, United States, Vietnam)
Figure 2-9: Number of Patient Beds, 2009-2013
Table 2-3: Out-Of-Pocket, Other Private and Government Healthcare Expenditures in BRIC and Comparison Countries (South Africa, France, United Kingdom, United States, Germany,Thailand, Turkey, Japan, Australia, Italy, Poland, Argentina, Brazil, South Korea, China,Russia, Mexico, Indonesia, Vietnam, India, Nigeria)
THREE: TRENDS
Figure 3-1: Prevalence of Diabetes in Adults by Age, 2014
FOUR: IVD MARKET IN VIETNAM
Figure 4-1: Vietnam IVD Market, 2014 and 2019
Figure 4-2: Regional IVD Markets in Vietnam (South Central Coast, Mekong River Delta, Red
River Delta, Southeast, Northeast, Central Highlands, North Central Coast, South Central Coast)
Figure 4-3: Vietnam Clinical Chemistry Market, 2014 and 2019
Figure 4-4: Vietnam Point of Care Diabetes Market, 2014 and 2019
Figure 4-5: Vietnam Point of Care, Other Market, 2014 and 2019
Figure 4-6: Vietnam Immunoassays, Infectious Disease and Other Market, 2014 and 2019
Figure 4-7: Vietnam Urinalysis Market, 2014 and 2019
Figure 4-8: Vietnam Molecular Diagnostics Market, 2014 and 2019
Figure 4-9: Vietnam Coagulation Market, 2014 and 2019
Figure 4-10: Vietnam Histology Market, 2014 and 2019
Figure 4-11: Vietnam Hematology Market, 2014 and 2019
Figure 4-12: Vietnam Blood Testing and Typing Market, 2014 and 2019
Figure 4-13: Vietnam Flow Ctyometry Market, 2014 and 2019
Table 4-1: IVD Market in Vietnam by Segment (Clinical Chemistry, Microbiology-ID/AST,Microbiology-Molecular, POC Glucose, Other Point of Care, Immunoassays Infectious Disease, Other Immunoassays, Urinalysis, Molecular Diagnostics, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry, Total)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- bioMerieux
- Roche
- Abbott Laboratories, S.A.
- Siemens Healthcare
- Sysmex
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll